$40.02 -0.78 (%) GlaxoSmithKline Shs Sponsored American Deposit Receipt Repr 2 Shs - New York Stock Exchange, Inc.

Jun. 27, 2016 | 02:20 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. Brandes Makes a Variety of Reductions in 4th Quarter

    GuruFocus | Feb. 11, 2016 | 18:19PM EST
  2. Stock Futures Up As Oil Behaves; Syngenta Up On ChemChina Deal

    IBD | Feb. 3, 2016 | 09:03AM EST
  3. EXCLUSIVE: Inovio Plans On Producing Zika Vaccine By Q3 2016, Ready For Phase 1 Study By Q4

    Benzinga | Jan. 29, 2016 | 13:38PM EST
  4. Benzinga's M&A Chatter for Thursday January 28, 2015

    Benzinga | Jan. 28, 2016 | 23:27PM EST
  5. 10 Fund Managers Are Totally Wrong on GlaxoSmithKline

    GuruFocus | Jan. 26, 2016 | 14:59PM EST
  6. Stocks Bring High Dividend Yields to HOTCHKIS & WILEY

    GuruFocus | Jan. 14, 2016 | 12:05PM EST
  7. Dynavax Hepatitis B Vaccine Beats Glaxo's In Trial

    IBD | Jan. 7, 2016 | 15:40PM EST
  8. Dynavax Hepatitis B Vaccine Beats Glaxo's In Trial

    IBD | Jan. 7, 2016 | 14:51PM EST
  9. Jeff Auxier's Holdings Trading Below Peter Lynch Earnings Line

    GuruFocus | Jan. 4, 2016 | 17:46PM EST
  10. Cisco Systems, Microsoft and Intel Bring High Dividend Yields to First Eagle Investment

    GuruFocus | Jan. 4, 2016 | 14:02PM EST
  11. The 5 Top-Performing Big-Cap Drug Stocks Of 2015

    IBD | Dec. 30, 2015 | 14:16PM EST
  12. High Dividend Yield Ratios Are Hallmarks of Many Dodge & Cox Stakes

    GuruFocus | Dec. 21, 2015 | 10:58AM EST
  13. Glaxo's ViiV Acquiring Bristol-Myers' HIV Candidates

    IBD | Dec. 18, 2015 | 14:05PM EST
  14. John Rogers' Holdings Trading Below Peter Lynch Earnings Line

    GuruFocus | Dec. 16, 2015 | 16:40PM EST
  15. 3 Global Investment Ideas From Gurus

    GuruFocus | Dec. 10, 2015 | 14:57PM EST
  16. Relypsa Stock Jumps On Buyout Rumors

    IBD | Dec. 4, 2015 | 15:31PM EST
  17. Skin Disease Drug Costs Jump

    IBD | Nov. 25, 2015 | 18:34PM EST
  18. Valeant, Glaxo, Novartis Skin Drug Prices Have Soared

    IBD | Nov. 25, 2015 | 17:01PM EST
  19. Dodge & Cox Sells Most of Stakes in Chevron, GlaxoSmithKline

    GuruFocus | Nov. 17, 2015 | 18:46PM EST
  20. 3 Investment Ideas of Ariel Investment's Rupal Bhansali

    GuruFocus | Nov. 16, 2015 | 09:57AM EST
  21. Pfizer to Create a New Pharmaceutical Colossus

    GuruFocus | Nov. 5, 2015 | 13:20PM EST
  22. GlaxoSmithKline

    IBD | Oct. 28, 2015 | 18:47PM EST
  23. Gilead Beats Q3 Estimates As HIV Franchise Shines

    IBD | Oct. 27, 2015 | 17:03PM EST
  24. ISIS Pharmaceuticals Earns $5M from GSK for Initiation of Phase 1 Study of ISIS-GSK4-L Rx

    Benzinga | Oct. 26, 2015 | 07:03AM EST
  25. Benzinga's Top Upgrades

    Benzinga | Oct. 20, 2015 | 09:11AM EST
  26. IBM, Schlumberger PTs Lowered; Valeant Downgraded

    IBD | Oct. 20, 2015 | 08:38AM EST
  27. GlaxoSmithKline Has a High (and Dangerous) Dividend Yield

    GuruFocus | Oct. 19, 2015 | 14:32PM EST
  28. Tweedy Browne Global Value Adds to Stake in GlaxoSmithKline

    GuruFocus | Oct. 14, 2015 | 18:23PM EST
  29. Liquidia Technologies And GlaxoSmithKline Advance Existing Collaboration; GlaxoSmithKline Exercises Option For Inhaled Therapeutics

    Benzinga | Sep. 30, 2015 | 12:44PM EST
  30. 3 Big Drugs Likely To Hit The Market Soon

    IBD | Sep. 30, 2015 | 12:34PM EST
  31. Regulatory Update: GSK and Theravance Announce Intention to File Relvar(R) Ellipta(R) for COPD ...

    GuruFocus | Sep. 25, 2015 | 00:03AM EST
  32. Guru Stocks at 52-Week Lows: RDS.A, PTR, UL, BP, GSK

    GuruFocus | Sep. 13, 2015 | 00:57AM EST
  33. Five Prime Therapeutics Announces Initial Data From Ongoing Phase 1b Trial of FP-1039 in Squamous NSCLC, Mesothelioma

    Benzinga | Sep. 10, 2015 | 04:33AM EST
  34. GSK and Theravance Announce Results From the SUMMIT COPD CV Survival Study

    GuruFocus | Sep. 9, 2015 | 00:02AM EST
  35. UPDATE: GlaxoSmithKline Says Tianjin Explosion Strained Supply Of Hepatitis-B Treatment Marketed In Japan

    Benzinga | Sep. 1, 2015 | 14:22PM EST
  36. GlasxoSmithKlien Says It Holds Sales Rights To Tenozet In Japan/China And Formulates Drug At Tianjin Plant Which Exploded

    Benzinga | Sep. 1, 2015 | 14:21PM EST
  37. Five Prime Therapeutics Announces Oral Presentation of Initial Data From Ongoing Phase 1b Trial of FP-1039/GSK3052230 in Squamous Non Small Cell Lung Cancer and Mesothelioma at World Conference on Lung Cancer

    Benzinga | Aug. 24, 2015 | 04:20AM EST
  38. Dodge & Cox Acquires Stake in Priceline

    GuruFocus | Aug. 21, 2015 | 18:31PM EST
  39. AptarGroup: The Leader in Dispensing Innovation

    GuruFocus | Aug. 21, 2015 | 15:31PM EST
  40. US Stock Futures Slide Ahead Of Deere, Foot Locker Earnings

    Benzinga | Aug. 21, 2015 | 07:06AM EST
  41. Novartis Acquires Rremaining Rghts to GSK's Ofatumumab to Develop Treatments for MS, Other Autoimmune Indications

    Benzinga | Aug. 21, 2015 | 04:34AM EST
  42. GSK Receives Approval for BREO(R) ELLIPTA(R) for the Treatment of Adults With Asthma

    GuruFocus | Aug. 7, 2015 | 00:04AM EST
  43. Gilead Q2 Earnings Soar As HCV Shines, HIV Rebounds

    IBD | Jul. 28, 2015 | 16:34PM EST
  44. Week Ahead: FOMC Meeting, GDP and More Earnings

    FoxBusiness | Jul. 24, 2015 | 16:28PM EST
  45. Novartis' Mixed Q2: Sandoz Booms, Alcon Struggles

    IBD | Jul. 21, 2015 | 13:15PM EST
  46. It's Not Too Late To Buy Gilead Sciences

    GuruFocus | Jul. 17, 2015 | 12:01PM EST
  47. Benzinga's Volume Movers

    Benzinga | Jul. 9, 2015 | 10:32AM EST
  48. Can Hepatitis B Be A Blockbuster Bug?

    IBD | Jul. 1, 2015 | 08:02AM EST
  49. BioMarin, Sarepta Muscular Dystrophy Drugs Progress

    IBD | Jun. 29, 2015 | 10:18AM EST
  50. Biotech IPOs Steam Ahead Despite Fears Of Overload

    IBD | Jun. 23, 2015 | 08:02AM EST
Trading Center